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Abstract
Background: Physical activity is linked to many positive health outcomes, stimulating the development of exercise programs. However, many 
falls occur while walking and so promoting activity might paradoxically increase fall rates, causing injuries, and worse quality of life. The 
relationship between activity exposure and fall rates remains unclear. We investigated the relationship between walking activity (exposure to 
risk) and fall rates before and after an exercise program (V-TIME).
Methods: One hundred and nine older fallers, 38 fallers with mild cognitive impairment (MCI), and 128 fallers with Parkinson’s disease 
(PD) were randomly assigned to one of two active interventions: treadmill training only or treadmill training combined with a virtual reality 
component. Participants were tested before and after the interventions. Free-living walking activity was characterized by volume, pattern, and 
variability of ambulatory bouts using an accelerometer positioned on the lower back for 1 week. To evaluate that relationship between fall risk 
and activity, a normalized index was determined expressing fall rates relative to activity exposure (FRA index), with higher scores indicating 
a higher risk of falls per steps taken.
Results: At baseline, the FRA index was higher for fallers with PD compared to those with MCI and older fallers. Walking activity did not 
change after the intervention for the groups but the FRA index decreased significantly for all groups (p ≤ .035).
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Conclusions: This work showed that V-TIME interventions reduced falls risk without concurrent change in walking activity. We recommend 
using the FRA index in future fall prevention studies to better understand the nature of intervention programs.
Keywords:  Falls, Parkinsons, Physical activity, Exercise, Wearable Technology
Each year, over 30% of older adults (>65 years) fall at least once, a 
figure that increases to 40%–80% among people with mild cognitive 
impairment (MCI) or Parkinson’s disease (PD) (1,2). Falls are the 
primary cause of injurious death in older adults and lead to loss of 
functional independence and poor quality of life, including depres-
sion, social isolation, and reduction in walking activity, all this with 
a significant societal burden (3). Major research efforts have been 
directed to reduce falls risks, with varying levels of success (4).
Research into the circumstances of falls clearly shows that falls 
occur mostly while people are walking (being physically active) 
(5,6). Time spent upright and while walking therefore increases the 
exposure to the risk of a fall, highlighting the dynamic nature of fall 
risk (5–10). Maintaining walking activity, however, is important for 
a wide variety of reasons (eg, to maintain or improve cardiovascular 
fitness) and is, therefore, the focus of many clinical trials (11,12). 
A concern is that promoting physical activity might paradoxically 
be offset by an increase in fall rates, thus causing injuries and worse 
quality of life. Yet, the main outcome measure in falls trials is to 
document the occurrence and frequency of a fall, without taking 
into account any concurrent changes in walking-related exposure. 
For example, a marked reduction in falls after an intervention might 
theoretically be explained by a further loss of mobility, for example, 
because patients became more fearful of falling and hence more 
sedentary. Understanding the relationship between activity levels 
and falls rate is, therefore, fundamental for identifying clinically rele-
vant reduction in falls risk.
To date, however, the understanding of this relationship is not 
clear. Studies reported conflicting results where older adults with 
higher levels of activity sustained fewer falls (13), as opposed to 
others where higher levels of activity were associated with an in-
crease in falls (14). For people with PD, the situation is even more 
complicated with increasing disease severity. Specifically, people in 
early stages of PD initially have few falls per unit of activity, but 
show a concomitant increase over time as physical activity levels 
remain the same but postural stability and the safety of gait worsen 
with disease progression (11). The final stage is a reduction in falls 
due to progressive immobility as patients become confined to their 
wheelchair or bed (11). Examining falls risk and activity exposure 
(number of falls in relation to amount of activity) may offer a better 
understanding of falls risk, potentially showing a higher falls risk 
exposure for less active people both in older adults (8,13,15) and 
in people with PD (16). Previous work has looked at this aspect 
by using various metrics (eg, number of fallers per 1,000 physic-
ally active person-days (15), falls per 100 hours walked or falls per 
individual physical activity exposure time (13,16), falls over total 
number of steps taken (10)) in cross-sectional or in descriptive 
studies characterizing falls risk in various disease groups. Utility of 
these metrics in intervention studies has not been addressed. Our 
work extends this concept by proposing a normalized and custom-
ized index to quantify falls risk and activity exposure and applies it 
to an intervention study.
The main aims of this study were therefore twofold. First, to in-
vestigate the relationship between exposure to risk (activity) and 
falls events, by comparing three groups of older adults with falls 
(falls in the older adults; people with MCI; and people with PD). 
We measured activity objectively and continuously using wearable 
technology to provide a quantitative measure of walking activity in 
free-living conditions, allowing the risk/activity relationship to be 
more fully explicated (17–20). Second, to explore the relationship in 
the context of a clinical trial to better understand the impact of an 
exercise intervention aimed at reducing falls on this relationship. We 
used data from a randomized clinical trial (RCT), which was an in-
tensive treadmill-based intervention with and without virtual reality 
(V-TIME). The results showed a significant reduction in number of 
falls in older adults from three groups (older fallers, people with 
PD and people with MCI) (21). In order to describe the relation-
ship between exposure to falls risk (activity levels) and falls events 
per se, we propose an index that is customizable and normalized 
to walking activity to better explore the relationship of falls risk 
(rate of falls) relative to exposure (walking activity): the Falls Rate 
to Activity (FRA) index. More specifically, we hypothesized that the 
falls rate relative to activity exposure would be higher in people with 
PD compared to older adults and to people with MCI. We further 
hypothesized that the V-TIME intervention—which aimed to reduce 
falls—would decrease the FRA index in all three groups (ie, that 
the reduction in falls reported previously following this intervention 
(22) would not be explained solely by a concurrent reduction in total 
walking activity, but rather by an intrinsic effect on fall risks per se).
Methods
Participants
Older adult fallers (older fallers, people with MCI and people 
with PD) were enrolled in the V-TIME study at five clinical centers 
across five countries (22). Participants were included if they were 
aged 60−90 years, able to walk for at least 5 minutes unassisted, on 
stable medication for the past month, and self-reported two or more 
falls within 6 months before screening. In addition to these criteria, 
people with MCI were included only if they had a score of 0.5 on 
the Clinical Dementia Rating scale. A detailed list of inclusion and 
exclusion criteria is described elsewhere (22). All decisions about eli-
gibility were made before randomization.
Demographic data were recorded for each participant. V-TIME 
study testing took place at the five clinical sites. The study was con-
ducted according to the declaration of Helsinki and was approved 
by local Ethics Committees. All participants signed an informed con-
sent form prior to testing (22).
Randomization, Intervention Protocol, and Falls 
Data Capture
Participants were randomly assigned to a 6-week, three times per 
week, 40-minute treadmill training only (TT) or treadmill training 
plus virtual reality (TT + VR) interventions. Study design and inter-
ventions are described in detail elsewhere (21,22).
Falls rate was recorded at baseline and during the 6 months after 
the end of the training. A fall was defined as “an unexpected event 
in which the participant comes to rest on the ground, floor or lower 
level” (23). According to their preference, participants were pro-
vided with a falls calendar as a paper version, web-based calendar, 
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or a smartphone application. Information logged in the online or 
smartphone-based calendar was automatically uploaded to a data-
base, whereas the paper calendars were posted back to the sites at 
which participants were recruited each month via preaddressed en-
velopes. Research staff contacted all participants every month to 
maximize compliance (21,22).
Free-Living Walking Activity Data Collection: 
Protocol
Participants were tested four times: preintervention (T1), and 
postintervention (after 1 week [T2], 1 month [T3], and 6 months 
[T4]). At the end of each time point, participants were asked to wear 
a tri-axial accelerometer-based wearable device (Axivity AX3, York, 
UK; dimensions: 23.0 × 32.5 × 7.6  mm; weight: 11  g; accuracy of 
the quartz-stabilized real-time clock: 20 parts per million) for 1 
week; this device has been validated for suitability in capturing high-
resolution data akin to human movement (24,25). The wearable was 
located on the fifth lumbar vertebra with a hydrogel adhesive (PAL 
Technologies, Glasgow, UK) and covered with the Hypafix ban-
dage for extra support. The wearable was programmed to capture 
data for 7  days at 100 Hz and at an acceleration range of ±8  g. 
Participants were asked to continue their daily activities as usual and 
not to change their routine. Upon completion of recording, the parti-
cipants removed the device and posted it back to the researcher (18).
Data Processing and Analysis
Data processing and variable extraction—free-living data
Once the wearable was received, data were downloaded and seg-
mented (per calendar day). For each day, individual ambulatory 
bouts (ABs) were extracted via MATLAB, where a “bout” was de-
fined as the continuous length of time spent walking (19). AB were 
detected by applying selective thresholds on the standard deviation 
and the magnitude vector of the triaxial accelerations (26). All ABs 
greater than 10 seconds (minimum bout length) were taken into 
account for the analysis (17–19,27–31); a threshold of 2.5 seconds 
was set for the maximum resting period between consecutive ABs; 
in other words, if there was a break of 2.5 seconds between two 
walking episodes, for example, it was considered as one AB (26).
Custom-made MATLAB programs were used to extract outcome 
measures. Pooled 7-day data were used for quantifying outcomes. 
Outcome measures were described according to a broad frame-
work that captured the overall volume (amount), pattern, and vari-
ability of walking activity (32). The outcomes specifically were the 
following: volume of walking (eg, number of steps per day), mean 
AB length was generated based on the AB detected over the 7 days. 
In addition, a set of nonlinear descriptors were also derived: (i) the 
pattern of ABs was quantified using alpha (α), which describes ABs 
distribution, evaluating the ratio of short to long ABs (eg, a high 
alpha means that the total walking time is made up of proportionally 
short ABs compared to long ABs) and (ii) the within AB variability 
(S2) of bout length estimated using a maximum likelihood technique 
(33,34).
An Index of Falls Rate to Activity (FRA index)
We quantified the falls risk taking into account changes in number 
of falls and walking activity (exposure) pre- and postintervention. 
We defined this as the “Falls Rate to Activity Index (FRA index),” a 
measure of exposure-adjusted incidence of falls. The FRA index can 
be applied flexibly because the denominator can be changed to suit 
the specific protocol of any falls study. For this study, we normalized 
falls over a set measure of walking exposure (100,000 steps) to en-
able comparability between studies. The FRA index describes the 
ratio between the number of falls reported in a given period of time 
(N days) prior to a walking activity assessment, and outcomes of the 
volume of walking activity (total number of steps per day, equation 
1), normalized per 100,000 steps (10,13,15,16,35).
In the case of V-TIME study, the FRA index describes the ratio 
between the number of falls reported in the previous 180  days 
(6 months, N = 180) of the free-living walking assessment, and out-
comes of the volume of walking activity (total number of steps per 
day, equation 2) normalized per 100,000 steps.
FRA index =
Number of Falls (past N days)
N days ∗ Total number of steps per day ∗ 100, 000
 
(1)
FRA index =
Number of Falls (past 180 days)
180 days ∗ Total number of steps per day ∗ 100, 000
 
(2)
To aid the interpretation of this index, it is directly proportional to 
number of falls and indirectly proportional to activity (number of 
steps taken per day), so a reduction in falls (or an increase in ac-
tivity) would reflect a numerical decrease in the index, thus reflecting 
a decrease in falls risk per 100,000 steps taken. On the other hand, a 
rise in falls (or a concurrent decrease in activity) would translate into 
a numerical increase of the index, thus reflecting a worsening falls 
risk per 100,000 steps taken. The index adjusts for activity levels, 
taking into account that a decrease in numbers of falls and a similar 
decrease in activity would not show a decrease in the index (so in 
falls risk) which would remain at the same level. So for example, if 
a person halved number of falls but at the same time halved his ac-
tivity, the index and therefore falls risk would remain the same. We 
quantified this index separately, for each time point (preintervention 
[T1] and 6  months postintervention [T4]), using walking activity 
and falls rate data from T1 (preintervention/baseline assessment) 
and T4 (6 months after the intervention assessment) in order to con-
sider the same period of time (6 months) for determining fall risk, 
with no overlap.
The advantage of the FRA index is that using a daily measure of 
volume of walking (ie, steps per day), it gives flexibility in relation to 
the period of time falls have been recorded/reported (eg, 6 months in 
our case) and with the additional normalization over 100,000 steps, 
it facilitates comparability across studies.
Statistical Analysis
Statistical analysis was carried out using SPSS v19 (IBM). 
Normality of data and homoscedasticity were tested with Shapiro-
Wilk test and Levene’s Test of Equality of Variances respectively. 
Descriptive statistics were reported as means and standard devi-
ations (SD).
We compared changes in activity levels. The effect of group 
(“pooled data”), time and type of intervention were examined using 
random effects linear mixed-models (RELM). We included type 
of intervention (TT vs TT + VR) as a fixed-effect and time (T1 vs 
T4), group (older fallers vs people with PD vs people with MCI), 
age and sex as covariates; random intercepts were modeled (36). 
We tested pre-postintervention change in the FRA index: we used 
nonparametric repeated measure tests as the index was not normally 
distributed. Analysis of outcome measures and FRA index was per-
formed on ambulatory bouts longer than 10 seconds.
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Following the methodology of the main V-TIME study, we include 
site as a covariate; the effect was not significant and site was therefore 
not included in any of the final models (data not shown). We referred 
to the modified intention-to-treat population used for the efficacy ana-
lyses as the full analysis set, which adhered as closely to the intention-
to-treat principle as was possible. The full analysis set included all 
participants who underwent randomization, satisfied eligibility criteria, 
had at least three training sessions, and had any assessments during 
the 6-month follow-up period. According to the intention-to-treat prin-
ciples, any participants who were randomly assigned to a group but 
discontinued the study before 6 months of follow-up were included 
into the full analysis set. Missing data resulting from dropouts, tech-
nical problems, and human errors were not imputed as per main study 
(22). We used a threshold of p < .05 to guide statistical interpretation 
for the main effects, while a Bonferroni corrected threshold (p < .0167) 
was used to account for the multiple comparisons (three groups).
Results
Of the 282 participants who completed training and were included 
in the main study full analysis set (22), 275 completed the free-living 
walking assessment (133 in the TT group and 142 in the TT + VR 
group (22), Supplementary Figure 1). The distribution of the three par-
ticipant subgroups (109 older fallers, 38 participants with MCI and 
128 participants with PD) was similar between the two intervention 
groups (52 in TT group vs 57 in the TT + VR group for older fallers; 
19 vs 19 for participants with MCI; 62 vs 66 for participants with PD). 
Participants’ baseline clinical and demographic characteristics are pre-
sented in Table 1. People with PD fallers were younger than older fallers 
and people with MCI and included proportionally fewer women (37%) 
than older fallers (78%) and people with MCI (68%). Baseline statis-
tical differences between the randomized groups are not reported (37).
Differences Between Groups Prior to Intervention
Walking activity
First, we describe the activity levels for each cohort. There was a 
significant effect of group (EF vs MCI vs PD), where the volume of 
walking (total walking time per day, percentage [%] of walking time 
per day, number of bouts, and steps per day) was lower in people with 
MCI and people with PD compared to older fallers (Table 2, p ≤ .012).
Falls Rate and Activity Exposure Index (the 
FRA index)
People with PD had a higher number of falls compared to both older 
fallers and people with MCI (p ≤ .036, Table  3). People with PD 
had a significantly higher FRA index compared to older fallers and 
people with MCI (significant effect of group by FRA index; p = .043, 
Table 3). Preintervention, people with PD experienced on average 2 
falls for every 100,000 steps versus 0.6 falls for older fallers and 0.2 
falls for people with MCI (Table 3).
Changes in Response to Intervention 
(Longitudinal data)
Walking activity
Walking activity did not change over time (main effect for Time, 
p > .068) irrespective of intervention type. In addition, there 
was no main intervention effect, significant Group × Time or 
Intervention × Time interactions.
Falls Rate and Activity Exposure Index (the 
FRA index)
The FRA index significantly decreased for all groups following 
both interventions, showing that falls risk reduced without this 
being explained by a concurrent reduction in walking activity 
levels (Table 3, Figure 1, p ≤ .035). For the whole group of partici-
pants (older fallers + people with PD + people with MCI), the FRA 
index significantly reduced from 0.9 to 0.6 (p < .001). Overall, the 
TT + VR intervention reduced the FRA index by 39% and the TT 
intervention by 26%. For all three groups, irrespective of inter-
vention, the FRA index significantly decreased postintervention 
(p ≤ .002, older fallers from 0.6 to 1.7, people with MCI from 0.2 
to 0.1 and people with PD from 2.0 to 1.6, Table 3). To quantify 
the reduction of this falls risk, we will provide one example here. 
Preintervention (T1), older fallers on average experienced 0.6 falls 
for every 100,000 steps, and this decreased to 0.2 falls after the 
intervention (T4), thereby significantly reducing this adjusted falls 
risk by approximately two thirds (Table 3). Results were similar 
also when we used T2, T3, and averaged (T2, T3, and T4) total 
number of steps per day values for the denominator of the index 
(Supplementary Table 1).
Table 1. Clinical and Demographic Characteristics for Idiopathic Older Fallers, Fallers with MCI and Fallers with PD at Baseline
Characteristics
Older Fallers 
(n = 109) Mean (SD)
Fallers with MCI  
(n = 38) Mean (SD)
Fallers with PD 
(n = 128) Mean (SD)
Intervention (TT/TT + VR) 52/57 19/19 62/66
Female (n, %) 85, 78% 26, 68% 47, 37%
Age (years) 75.93 (6.22) 78.03 (6.21) 71.68 (6.43)
BMI (kg/m2) 26.02 (4.26) 26.28 (4.56) 25.96 (3.62)
MMSE 28.52 (1.36) 25.95 (2.4) 28.07 (1.68)
Hoehn and Yahr (HY) stage (%) - - HY 2–48%  
HY 2.5–10%  
HY 3–42%
MDS-UPDRS III - - 30.37 (16.96)
Freezing of gait (%, Score) - - 59%, 9.16 (9.33)
FES-I (16–64) 28.76 (7.67) 30.38 (10.11) 34.98 (11.73)
Note: BMI = Body Mass Index; FES-I = Falls Efficacy Scale; MCI = Mild Cognitive Impairment; MMSE = Mini-Mental State Examination; MDS-UPDRS 
III = Movement Disorder Society Unified Parkinson’s Disease Rating Scale part III; PD = Parkinson’s disease.
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Table 2. Free-Living Outcomes for Participants Grouped as OF, Fallers with MCI and Fallers with PD, Preintervention (T1) and 6 Months 
Postintervention (T4)
ABs > 10 s T1 (preintervention) T4 (6 months postintervention)
TT Older Fallers
Fallers with 
MCI Fallers with PD Older Fallers
Fallers with 
MCI Fallers with PD
Volume
  Total Walking Time per Day 
(Min)a
128.6 (58.3) 125.2 (48.7) 117.3 (59.1) 119.7 (64.0) 116.4 (61.8) 116.2 (65.1)
 Percentage of Walking Timea 8.9 (4.1) 8.7 (3.4) 8.2 (4.1) 8.3 (4.5) 8.1 (4.3) 8.1 (4.5)
 Number of steps per Daya 9,833 (4,793) 9,354 (3,712) 8,874 (4,538) 8,993 (5,092) 8,765 (4,723) 8,654 (4,638)
 Bouts per Daya 264 (105) 268 (98) 233 (106) 250 (94) 254 (129) 229 (116)
 Mean Bout Length (sec)b 28.9 (5.7) 27.8 (4.4) 29.8 (5.8) 28.0 (6.4) 27.2 (3.7) 30.4 (6.3)
Variability
 Variability (S2) 0.620 (0.095) 0.605 (0.082) 0.630 (0.094) 0.599 (0.094) 0.595 (0.076) 0.636 (0.100)
Pattern
 Alpha (α) 2.621 (0.27) 2.650 (0.23) 2.553 (0.299) 2.658 (0.258) 2.619 (0.144) 2.515 (0.247)
 TT + VR Older Fallers Fallers with MCI Fallers with PD Older Fallers Fallers with MCI Fallers with PD
Volume
  Total Walking Time per Day 
(Min)a
142.2 (59.9) 113.4 (41.2) 117.8 (62.3) 137.7 (64.8) 107.4 (36.7) 127.9 (84.3)
 Percentage of Walking Timea 9.9 (4.2) 7.9 (2.9) 8.2 (4.3) 9.6 (4.5) 7.5 (2.6) 8.9 (5.9)
 Number of steps per Daya 10,802 (4,700) 8,252 (3,218) 9,000 (4,535) 10,423 (5,274) 8,032 (2,942) 9,468 (5,576)
 Bouts per Daya 288 (97) 261 (84) 242 (110) 282 (99) 248 (86) 254 (107)
 Mean Bout Length (seconds)b 29.2 (6.0) 25.9 (3.1) 28.4 (4.9) 28.3 (6.7) 26.0 (2.5) 29.0 (7.0)
Variability
 Variability (S2) 0.612 (0.091) 0.562 (0.063) 0.606 (0.083) 0.594 (0.108) 0.569 (0.050) 0.607 (0.104)
Pattern
 Alpha (α) 2.555 (0.209) 2.690 (0.237) 2.587 (0.274) 2.597 (0.276) 2.691 (0.185) 2.557 (0.271)
Note: Longitudinal data are presented for each intervention arm, for all ambulatory bouts longer than 10 seconds (ABs > 10 s). Values are presented as mean 
(SD).
OF = Older Fallers; MCI = Mild cognitive impairment; PD = Parkinson’s disease; TT = Treadmill training only intervention; TT + VR = Treadmill training plus 
virtual reality intervention.
aSignificant (p < .05) Group effect (OF vs MCI vs PD); bsignificant (p < .05) Group × Intervention interaction.
Table 3. FRA Index Together with Number of Falls and Step Per Day Results Preintervention (T1) and 6 Months Postintervention (T4) for 
Idiopathic OF, Older Fallers with MCI, and Fallers with PD
ABs > 10 s T1 (preintervention) T4 (6 months postintervention)
TT Older Fallers Fallers with MCI Fallers with PD Older Fallers Fallers with MCI Fallers with PD
FRA Indexa
 Mean (SD) 0.640 (2.839)b 0.210 (0.181)b 2.440 (5.941)b 0.074 (0.191)b 0.185 (0.5)b 2.177 (7.846)b
 Median (IQR) 0.146 (0.209) 0.159 (0.159) 0.271 (0.972) 0 (0.054) 0 (0.089) 0.061 (0.68)
Number of Fallsa
 Mean (SD) 3.278 (2.476) 2.857 (1.352) 26.478 (67.962) 0.815 (1.854) 1.286 (2.61) 14.955 (57.392)
 Median (IQR) 2 (1) 2 (1.5) 3 (5) 0 (1) 0 (2) 1 (6)
 Number of steps per Daya 9,833 (4,793) 9,354 (3,712) 8,874 (4,538) 8,993 (5,092) 8,765 (4,723) 8,654 (4,638)
TT + VR
FRA Indexa
 Mean (SD) 0.487 (1.717)b 0.248 (0.157)b 1.573 (4.732)b 0.257 (1.35)b 0.098 (0.209)b 1.052 (4.472)b
 Median (IQR) 0.127 (0.193) 0.214 (0.145) 0.261 (0.292) 0 (0.105) 0 (0.077) 0.104 (0.378)
Number of Fallsa
 Mean (SD) 8.017 (28.493) 3.2 (1.576) 17.691 (51.06) 4.75 (27.658) 2.4 (4.86) 6.971 (17.225)
 Median (IQR) 2 (1) 2.5 (2.75) 3 (3) 0.5 (2) 1 (1.75) 2 (5.75)
Number of steps per Daya 10,802 (4,700) 8,252 (3,218) 9,000 (4,535) 10,423 (5,274) 8,032 (2,942) 9,468 (5,576)
Note: Longitudinal data are presented for each intervention arm for all ambulatory bouts longer than 10s (ABs > 10 s).
OF = Older Fallers; FRA = Falls Rate to Activity; MCI = Mild Cognitive Impairment; IQR = Interquartile range; PD = Parkinson’s disease; SD = Standard 
deviation; TT = Treadmill training only intervention; TT + VR = Treadmill training plus virtual reality intervention.
aSignificant (p < .05) Group effect (OF vs MCI vs PD); bsignificant (p < .05) Time effect.
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Discussion
Our primary aim was to evaluate the relationship between exposure 
to falls risk (total activity levels) and falls events (expressed as the 
normalized FRA index) in three groups of older adults with falls, 
and to explore the effect of an intervention aimed to reduce falls 
(V-TIME) using this FRA index as outcome. The FRA index im-
proved postintervention for all groups. This was driven by a true re-
duction in falls frequency, as activity levels remained the same. These 
findings are important as they provide a more nuanced approach to 
measuring falls status than usual measures. As such, the FRA index 
paints a clearer picture of the true impact of interventions aimed at 
reducing falls risk.
Differences in Falls Risk Relative to Activity Levels 
Across Different Cohorts of Fallers
Walking activity was lower in people with PD and with MCI com-
pared to older fallers, while falls rates were higher in people with PD. 
In line with previous research, we also found that people with PD 
and with MCI walked less than older fallers (18,38). Importantly, 
we found that people with PD had the highest FRA index relative to 
older fallers and people with MCI, confirming the higher falls risk in 
people with PD in the older adults’ spectrum, but now even when time 
spent being active is considered (1,21). Specifically, preintervention 
people with PD experienced two falls every ~100,000 steps com-
pared to 0.6 for older fallers and 0.2 for people with MCI. Although 
it is difficult to compare our study with others due to differences in 
the quantification of falls incidence and activity levels, this finding 
is in agreement with previous studies looking at fall incidents and 
exposure to activity in people with PD (16).
Previous studies in older adults and people with PD showed 
that including metrics of exposure to activity (falls per 100 hours 
walked) and falls incidence might be a sensitive measure of falls risk 
(13,16). A key difference in our work is that the FRA index quan-
tifies activity exposure using quantified numbers of steps per day, 
rather than an estimate of hours spent walking (13,15), this aids the 
clinical interpretability of the results as often guidelines on recom-
mended walking activity levels are expressed as the number of steps 
(per day). But another benefit of the outcome measure “falls per ac-
tivity” captured by the FRA index is that it is not limited to a specific 
denominator (steps or activity duration); depending on the purpose 
of the analysis and application, the denominator has the capability 
of flexibility in order to target specific activity metrics which may 
change with guidelines and field of application (eg, some activity 
guidelines express the recommendation as durations).
We consider the FRA index a preliminary but important step to-
ward addressing the past and ongoing work on fall risk models and 
the recognized need to consider exposure (activity) and context (en-
vironment) in addition to intrinsic factors (eg, age, sex, etc.) to fully 
characterize falls risk (8,39).
The Effect of an Exercise-Based Intervention 
(V-TIME) on Falls Risk
To understand the effect of exercise, it was necessary to first de-
termine changes in activity levels following the intervention. We 
showed that walking activity (for any of its measures) did not 
change significantly following the intervention, irrespective of 
group or intervention arm. We further showed that the FRA index 
decreased significantly for all groups, irrespective of the interven-
tion, showing a postintervention decrease in falls, driven by a drop 
in falls rate rather than a decrease in walking activity (exposure). In 
contrast with what was shown in the main study, we did not find an 
intervention effect for the FRA index (TR vs TT + VR). This may 
be due to the reduced number of participants that were included in 
this analysis, limited by the availability of free-living walking data. 
Participants managed to reduce their falls risk by decreasing the 
number of falls without reducing their walking activity/exposure. 
The decrease in the FRA index, therefore, indicated the reduction 
in the number of falls, taking into account exposure to activity. The 
V-TIME trial was therefore successful in reducing falls and also 
significantly reducing falls risk.
Changing Walking Activity
It could be argued that the optimal result of an exercise-based inter-
vention would be a reduction in falls accompanied by an increase in 
activity. Note that the V-TIME intervention was focused exclusively 
on a lab-based exercise intervention aimed to reduce falls, but no 
attempt was made to increase physical activities in the patients’ own 
home environment in between the hospital visits. In this regard, an 
important finding is that the volume of walking activity did not get 
lower in any of the three groups, but was actually maintained; this 
can be seen as a positive outcome because previous studies showed 
the importance of maintaining activity levels to decrease falls risk 
(11,12). It is also important to note that over a regular 6-month 
observation period, that is, without any intermittent intervention 
such as V-TIME, one might expect to see spontaneous reductions in 
walking activity in PD patients (40) and older adults.
Limitations
Further work is needed to assess the merits of our initial analysis, espe-
cially in studies targeting increases in walking behavior. In addition, 
the examination of other diseases with a history of falls will allow 
us to identify specific interventions/rehabilitation strategies for redu-
cing falls risk while maintaining walking activity levels. Future work 
also needs to address specific technical limitations of instrumented 
free-living walking assessment (eg, examining the effect of merging 
short ambulatory bouts on results) for considering a broader impact 
of the interventions on walking behavior. We recorded walking ac-
tivity for only 1 week, which may not be enough to capture a reli-
able impression of a person’s true physical activity levels over longer 
periods of time (eg, subjects may have behaved differently during the 
week of observation). Inclusion of walkability data of towns should 
also be considered in future studies, in fact walkability has recently 
been shown to be an important factor impacting walking activity 
and falls risk (41,42). Finally, the preintervention falls rate was based 
Figure 1. Falls Rate to Activity Index (FRA index) results preintervention (T1, 
white bars) and 6  months postintervention (T4, black bars) for idiopathic 
Older Fallers, older fallers with Mild Cognitive Impairment (MCI), and 
fallers with Parkinson’s disease (PD), evaluated in free-living conditions. * 
represents post-hoc significant differences (p values < 0.05). TT = Treadmill 
training only intervention; TT + VR  =  Treadmill training plus virtual reality 
intervention.
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on participants’ recall, while postintervention falls rate on falls diary, 
this may have impacted on the reported preintervention outcomes 
as asking people to recall falls might lead to underreporting (43). 
Ideally, the pairing of objective walking activity and objective falls 
detection methods would improve sensitivity of this type of outcome 
(eg, FRA index).
Conclusions
Our findings suggest the utility and sensitivity of using a custom-
izable and normalized FRA index to better understand and disen-
tangle the effect of clinical trials testing the efficacy of interventions 
on fall rates and walking activity levels in populations at risk of 
falling. In our specific example, the V-TIME intervention successfully 
reduced falls risks while maintaining walking activity levels across 
different cohorts of older adult fallers.
Supplementary Material
Supplementary data are available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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